289 related articles for article (PubMed ID: 34224008)
1. Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus.
Ando F
Clin Exp Nephrol; 2021 Oct; 25(10):1051-1056. PubMed ID: 34224008
[TBL] [Abstract][Full Text] [Related]
2. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.
Ando F; Mori S; Yui N; Morimoto T; Nomura N; Sohara E; Rai T; Sasaki S; Kondo Y; Kagechika H; Uchida S
Nat Commun; 2018 Apr; 9(1):1411. PubMed ID: 29650969
[TBL] [Abstract][Full Text] [Related]
3. Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus.
Ando F; Uchida S
Clin Exp Nephrol; 2018 Jun; 22(3):501-507. PubMed ID: 29478202
[TBL] [Abstract][Full Text] [Related]
4. Regulation of aquaporin-2 trafficking.
Nedvetsky PI; Tamma G; Beulshausen S; Valenti G; Rosenthal W; Klussmann E
Handb Exp Pharmacol; 2009; (190):133-57. PubMed ID: 19096775
[TBL] [Abstract][Full Text] [Related]
5. LRBA signalosomes activate vasopressin-induced AQP2 trafficking at recycling endosomes.
Yanagawa H; Hara Y; Ando F; Suzuki S; Fujiki T; Oikawa D; Yui N; Mandai S; Mori Y; Susa K; Mori T; Sohara E; Tokunaga F; Uchida S
J Physiol; 2023 Dec; 601(23):5437-5451. PubMed ID: 37860942
[TBL] [Abstract][Full Text] [Related]
6. Physiological insights into novel therapies for nephrogenic diabetes insipidus.
Sands JM; Klein JD
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1149-F1152. PubMed ID: 27534996
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.
Olesen ET; Rützler MR; Moeller HB; Praetorius HA; Fenton RA
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12949-54. PubMed ID: 21768374
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
[TBL] [Abstract][Full Text] [Related]
9. Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts.
Klein JD; Wang Y; Blount MA; Molina PA; LaRocque LM; Ruiz JA; Sands JM
Am J Physiol Renal Physiol; 2016 May; 310(10):F1008-12. PubMed ID: 26962099
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic drugs upregulate aquaporin-2 via vasopressin-2 receptor/cAMP/protein kinase A signaling in inner medullary collecting duct cells.
Kim S; Jo CH; Kim GH
Am J Physiol Renal Physiol; 2021 May; 320(5):F963-F971. PubMed ID: 33843270
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
Vukićević T; Hinze C; Baltzer S; Himmerkus N; Quintanova C; Zühlke K; Compton F; Ahlborn R; Dema A; Eichhorst J; Wiesner B; Bleich M; Schmidt-Ott KM; Klussmann E
J Am Soc Nephrol; 2019 May; 30(5):795-810. PubMed ID: 30988011
[TBL] [Abstract][Full Text] [Related]
12. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Boone M; Kortenoeven M; Robben JH; Deen PM
Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
[TBL] [Abstract][Full Text] [Related]
13. Updates and Perspectives on Aquaporin-2 and Water Balance Disorders.
Noda Y; Sasaki S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884753
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.
Ando F; Sohara E; Morimoto T; Yui N; Nomura N; Kikuchi E; Takahashi D; Mori T; Vandewalle A; Rai T; Sasaki S; Kondo Y; Uchida S
Nat Commun; 2016 Nov; 7():13636. PubMed ID: 27892464
[TBL] [Abstract][Full Text] [Related]
15. The Vasopressin Receptor 2 Mutant R137L Linked to the Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Signals through an Alternative Pathway that Increases AQP2 Membrane Targeting Independently of S256 Phosphorylation.
Ranieri M; Venneri M; Pellegrino T; Centrone M; Di Mise A; Cotecchia S; Tamma G; Valenti G
Cells; 2020 May; 9(6):. PubMed ID: 32486031
[TBL] [Abstract][Full Text] [Related]
16. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
Gao C; Higgins PJ; Zhang W
Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
[TBL] [Abstract][Full Text] [Related]
17. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice.
Procino G; Milano S; Carmosino M; Barbieri C; Nicoletti MC; Li JH; Wess J; Svelto M
Kidney Int; 2014 Jul; 86(1):127-38. PubMed ID: 24522493
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic diabetes insipidus.
Bichet DG
Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
Deen PM; Knoers NV
Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-Dependent Kinase 18 Controls Trafficking of Aquaporin-2 and Its Abundance through Ubiquitin Ligase STUB1, Which Functions as an AKAP.
Dema A; Faust D; Lazarow K; Wippich M; Neuenschwander M; Zühlke K; Geelhaar A; Pallien T; Hallscheidt E; Eichhorst J; Wiesner B; Černecká H; Popp O; Mertins P; Dittmar G; von Kries JP; Klussmann E
Cells; 2020 Mar; 9(3):. PubMed ID: 32164329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
